<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to patients with inflammatory bowel disease and loss of response to anti-TNF therapy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to patients with inflammatory bowel disease and loss of response to anti-TNF therapy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Approach to patients with inflammatory bowel disease and loss of response to anti-TNF therapy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This figure summarizes the general approach to drug monitoring for adults who had initially responded to anti-TNF therapy for IBD but who develop loss of response. Anti-TNF agents for maintaining remission in IBD include adalimumab, certolizumab pegol, golimumab, and infliximab. Adalimumab and infliximab are used for treating either Crohn disease or ulcerative colitis, whereas certolizumab pegol is used for treating Crohn disease and golimumab is used for treating ulcerative colitis. Drug monitoring can help inform whether escalating the dose or switching to a different drug is preferred. This algorithm is intended for use in conjunction with other UpToDate content. Refer to the UpToDate topic on dosing and monitoring of anti-TNF agents for additional details.</div><div class="graphic_footnotes"><p>CRP: C-reactive protein; IBD: inflammatory bowel disease; JAK: Janus kinase; TNF: tumor necrosis factor.</p>
<p>* Examples of other drug classes for IBD include anti-12/23 antibody therapy, anti-integrin therapy, and JAK inhibitor therapy.</p>
<p>¶ Reporting of anti-drug antibodies varies among laboratories and has not been standardized. In general, low antibody levels occur with detectable drug levels, whereas high antibody levels usually occur when drug levels are undetectable.</p>
<p>Δ Immunomodulators that are typically used in combination with anti-TNF agents include azathioprine, 6-mercaptopurine, or methotrexate.</p>
◊ Options for escalating anti-TNF therapy include shortening dosing interval or increasing drug dose.</div><div id="graphicVersion">Graphic 143130 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
